Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||FC889 / 2||- / -|
Administered by: Other Purchased by: ??
Symptoms: Cerebral haemorrhage, Death, Nervous system disorder
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: LANTUS; JANUVIA [SITAGLIPTIN]; ROSUVASTATIN; METFORMAX
Preexisting Conditions: Medical History/Concurrent Conditions: Diabetes
Diagnostic Lab Data:
CDC 'Split Type': BEPFIZER INC2021688133
Write-up: Death; Nervous system disorder; Cerebral hemorrhage; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB BE-FAMHP-DHH-N2021-95019. A 69-years-old male patient received second dose of BNT162B2 (COMIRNATY), via an unspecified route of administration on 28May2021 (Lot Number: FC889) as single dose for covid-19 immunisation. Medical history included diabetes. Concomitant medications included insulin glargine (LANTUS); sitagliptin (JANUVIA); rosuvastatin; metformin hydrochloride (METFORMAX). The patient previously received first dose of BNT162B2 (COMIRNATY), via an unspecified route of administration on unspecified date (Lot /batch number unknown) as single dose for covid-19 immunisation. The patient experienced nervous system disorder, death and cerebral hemorrhage on 01Jun2021. The patient died on 03Jun2021. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Nervous system disorder; Cerebral hemorrhage; Death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166